May 9, 2018 / 8:21 PM / 2 months ago

BRIEF-Amphastar Pharmaceuticals Q1 GAAP Loss Per Share $0.16

May 9 (Reuters) - Amphastar Pharmaceuticals Inc:

* AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2018

* Q1 GAAP LOSS PER SHARE $0.16

* Q1 REVENUE $58.4 MILLION VERSUS I/B/E/S VIEW $60.8 MILLION

* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.05

* Q1 EARNINGS PER SHARE VIEW $0.08 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below